von Sprecher A, Beck A, Gerspacher M, Sallmann A, Anderson G P, Subramanian N, Niederhauser U, Bray M A
Research Department, CIBA-GEIGY Ltd., Basel, Switzerland.
J Lipid Mediat. 1993 Mar-Apr;6(1-3):265-73.
The research of the last two decades in the field of SRS-A and peptidoleukotriene (pLT) antagonists has provided information for the design of potent pLT antagonists, which share some or all of the following structural elements: (1) a lipophilic anchor, which fits into the lipophilic pocket of the LTD4 receptor; (2) a central lipophilic unit mimicking the tetraene system of LTD4; (3) one or two acidic groups, as mimics of the cysteinyl-glycine unit and/or the carboxylic group in the eicosanoid backbone of LTD4; (4) spacers connecting these elements. Potent pLT antagonists lacking a second polar binding group compensate by stronger interaction in other regions of the receptor. Identification of pLT antagonists is based on lead optimisation, preparation of pLT analogs and on the knowledge of the pLT receptor.
过去二十年来在慢反应物质A(SRS - A)和肽白三烯(pLT)拮抗剂领域的研究为设计强效pLT拮抗剂提供了信息,这些拮抗剂具有以下部分或全部结构要素:(1)一个亲脂性锚定基团,可嵌入白三烯D4(LTD4)受体的亲脂性口袋;(2)一个模拟LTD4四烯系统的中心亲脂性单元;(3)一个或两个酸性基团,模拟半胱氨酰 - 甘氨酸单元和/或LTD4类二十烷酸骨架中的羧基;(4)连接这些要素的间隔基团。缺少第二个极性结合基团的强效pLT拮抗剂通过与受体其他区域更强的相互作用来弥补。pLT拮抗剂的鉴定基于先导化合物优化、pLT类似物的制备以及对pLT受体的了解。